Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

QiC Oncology

- PMLiVE

David Prior to chair UK Care Quality Commission

Replaces Dame Jo Williams

- PMLiVE

Gilead expands in cancer with $510m YM BioSciences deal

Lands JAK inhibitor CYT387

- PMLiVE

First wave of CCGs authorised

New NHS groups will serve 10 million people

- PMLiVE

Healthwatch England names Katherine Rake as director

Former advisor to Prime Minister will lead body to give patients in England a say in health policy

- PMLiVE

Andrew Gengos joins ImmunoCellular as CEO

Will lead company as it initiates phase II trials investigating brain tumour vaccine

- PMLiVE

FDA approves Exelixis’ Cometriq for rare thyroid cancer

Genomics-based discovery company also submits the drug to EU regulators

Charles Morris appointed chief development officer at ImmunoGen

Previously worked in oncology for Allos, Cephalon and AstraZeneca

- PMLiVE

NHS data is key to sustaining drug research in UK

ABPI, BIA and NOCRI event told shared knowledge is central to effective partnerships

- PMLiVE

NHS confirms departure of Jim Easton to Care UK

Joins private provider from public sector

Eisai: Bucking the trend with R&D growth

PME’s emerging companies series continues with a firm that’s committed to research as it expands its commercial position

- PMLiVE

Medicines optimisation will be ‘core business’ for UK pharma

Chief pharmaceutical officer says industry will be a key partner in the agenda

- PMLiVE

Roche’s Avastin cuts progression of aggressive brain cancer

Supports potential new indication for oncology medicine

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links